Research · head to head
Remesh vs STARLIMS
Remesh
Research
Live AI-moderated conversations with hundreds of participants at once, analysed in real time
- From
- On request
- Rated
- -
STARLIMS
Research
Laboratory information management from Abbott for regulated and public health labs
- From
- On request
- Rated
- -
The short version
- Each has a real cost: Remesh pricing is not published and third-party estimates put annual contracts in the tens of thousands of dollars, which puts it out of reach for teams that only run occasional qualitative studies and cannot commit to an annual platform fee.; STARLIMS implementation is lengthy and outcome quality depends heavily on the partner doing the configuration
- They diverge on capability: Remesh covers Live moderated sessions, STARLIMS covers Sample and specimen management.
- Prices and features above were last checked on 31 August 2026.
Where they differ
Only the attributes on which Remesh and STARLIMS actually diverge.
Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).
What each one covers
Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.
Only in Remesh
- Live moderated sessions
- Collective dialogue
- Flex asynchronous studies
- Video research
- Remy AI assistant
- On-Demand Recruit
- Real-time theme analysis
- Practice sessions
Only in STARLIMS
- Sample and specimen management
- Quality management
- Instrument integration
- Public health reporting
- Regulatory compliance
- Web and mobile access
What people use each for
The jobs each tool is most often brought in to do.
Remesh
- A brand team that needs to test three positioning statements with 400 target customers and know by the end of the day which one lands and with whomnot STARLIMS
- An HR function running an employee listening session across several thousand staff where anonymity and volume both matternot STARLIMS
- A public affairs team needing rapid citizen consultation on a policy option with evidence of how widely each objection is heldnot STARLIMS
- An insights team that has to replace six focus groups with one session because fieldwork time has been cut and the decision cannot waitnot STARLIMS
STARLIMS
- Public health laboratories handling surveillance and outbreak investigationnot Remesh
- Clinical laboratories needing regulated specimen tracking and reportingnot Remesh
- Food safety and environmental testing laboratoriesnot Remesh
- Multi-site laboratory networks standardising methods and specificationsnot Remesh
Where each one falls short
Documented limitations, not opinions. Every one is a constraint you would hit in normal use.
Remesh
- Pricing is not published and third-party estimates put annual contracts in the tens of thousands of dollars, which puts it out of reach for teams that only run occasional qualitative studies and cannot commit to an annual platform fee.
- The public review picture is inconsistent in a way worth investigating: a small number of positive buyer reviews on G2 sit alongside a poor Trustpilot rating driven mostly by participant complaints, so ask directly how participants are recruited and compensated before running a study on your own customers.
- Funding has slowed sharply, from a 25 million USD round in 2021 to a 4.25 million USD round in late 2022, so procurement teams at large organisations should expect to run a vendor viability review.
- The collective dialogue mechanic rewards views that many participants recognise and vote for, which systematically under-weights genuinely novel minority insight, so it is a poor fit for exploratory discovery work where the outlier is the point.
- The discussion guide builder, especially spreadsheet import, is reported as unreliable, and because sessions are live with recruited participants a tooling failure during setup is expensive rather than merely annoying.
STARLIMS
- Implementation is lengthy and outcome quality depends heavily on the partner doing the configuration
- Pricing is quote-based with no public reference, making early budget setting difficult
- The breadth across laboratory types means some verticals get less development attention than others
- Interface modernisation has lagged behind newer cloud-native laboratory platforms
- Over-specified for small laboratories, where a lighter LIMS delivers most of the value for a fraction of the effort
Pricing, plan by plan
Remesh
On request- Remesh$undefined/year
- Live moderated sessions
- Flex asynchronous studies
- Video research
STARLIMS
On request- STARLIMS$undefined/year
- Sample management
- Quality management
- Instrument integration
Which should you pick?
Choose Remesh if
- You need live moderated sessions.
- You work on Web, API.
- You also want collective dialogue.
Choose STARLIMS if
- You need sample and specimen management.
- You work on Web, Windows, Cloud, On-premise.
- You also want quality management.
Questions people ask
- Is Remesh or STARLIMS better?
- Neither clearly leads. Remesh starts at On request and STARLIMS at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
- Which is cheaper, Remesh or STARLIMS?
- Remesh starts at On request and STARLIMS at On request.
- Does Remesh or STARLIMS run on more platforms?
- Remesh runs on Web, API. STARLIMS runs on Web, Windows, Cloud, On-premise.
- What is Remesh best used for?
- Remesh is most often used for a brand team that needs to test three positioning statements with 400 target customers and know by the end of the day which one lands and with whom, an hr function running an employee listening session across several thousand staff where anonymity and volume both matter, a public affairs team needing rapid citizen consultation on a policy option with evidence of how widely each objection is held, an insights team that has to replace six focus groups with one session because fieldwork time has been cut and the decision cannot wait. Of those, a brand team that needs to test three positioning statements with 400 target customers and know by the end of the day which one lands and with whom and an hr function running an employee listening session across several thousand staff where anonymity and volume both matter are not what STARLIMS is typically brought in for.
- What can Remesh do that STARLIMS cannot?
- Remesh covers Live moderated sessions, Collective dialogue, Flex asynchronous studies, Video research. STARLIMS covers Sample and specimen management, Quality management, Instrument integration, Public health reporting.
Answered from the vendors’ own pages
Remesh: How many people can join one session?
Sessions are designed for several hundred participants at once, which is the core reason to choose it over a conventional focus group.
STARLIMS: Who owns STARLIMS?
Abbott. That gives it institutional weight in laboratory procurement and a natural relationship with Abbott diagnostic instruments.
Remesh: Does it publish pricing?
No. Contracts are quoted annually, typically scoped by session volume, and third-party estimates place them in the tens of thousands of dollars per year.
STARLIMS: Where is it strongest?
Public health and clinical laboratories. Surveillance reporting, outbreak investigation and unpredictable specimen surges are different problems from pharmaceutical QC, and it handles them well.
Remesh: Can it replace a survey?
Not entirely. It produces open-ended language with agreement percentages, which is stronger than a survey for understanding reasoning but weaker for precise population estimates.
STARLIMS: What does it cost?
Not published. Enterprise licensing plus implementation, quoted on laboratory count, users and modules.
Remesh: Does Remesh recruit participants for me?
Yes, through On-Demand Recruit, typically delivering a panel within about 24 hours, or you can bring your own list.
STARLIMS: How does it compare to LabWare?
Both are enterprise LIMS with regulatory depth. LabWare is more dominant in pharmaceutical QC; STARLIMS has more presence in public health and clinical. Implementation partner quality matters more than the platform difference.
STARLIMS: What decides a successful implementation?
Configuration and validation quality, not platform features. Evaluations that compare feature lists rather than implementation approach are asking the wrong question.
Related pages
Other head to heads
- Remesh vs Dovetail
- Remesh vs Suzy
- Remesh vs Aurelius
- Remesh vs SurveyMonkey
- Remesh vs Zappi
- Remesh vs GWI
- Remesh vs TetraScience
- Remesh vs NVivo
- Remesh vs Condens
- Remesh vs Greenphire
- Remesh vs Marvin
- Remesh vs Castor EDC
- Remesh vs Chemaxon
- Remesh vs DNAnexus
- Remesh vs LabWare
- Remesh vs Thermo SampleManager LIMS
- Remesh vs LabVantage
- Remesh vs Benchling
- Remesh vs Sapio Sciences
- Remesh vs Labguru
- Remesh vs Scispot
- Remesh vs Medidata Rave
- Remesh vs Roam Research
- Remesh vs Contentsquare
- Remesh vs Terra
- Remesh vs Valispace
- Remesh vs Wolfram Mathematica
- STARLIMS vs Dovetail
- STARLIMS vs Suzy
- STARLIMS vs Aurelius
- STARLIMS vs SurveyMonkey
- STARLIMS vs Zappi
- STARLIMS vs GWI
- STARLIMS vs TetraScience
- STARLIMS vs NVivo
- STARLIMS vs Condens
- STARLIMS vs Greenphire
- STARLIMS vs Marvin
- STARLIMS vs Castor EDC
- STARLIMS vs Chemaxon
- STARLIMS vs DNAnexus
- STARLIMS vs LabWare
- STARLIMS vs Thermo SampleManager LIMS
- STARLIMS vs LabVantage
- STARLIMS vs Benchling
- STARLIMS vs Sapio Sciences
- STARLIMS vs Labguru
- STARLIMS vs Scispot
- STARLIMS vs Medidata Rave
- STARLIMS vs Roam Research
- STARLIMS vs Contentsquare
- STARLIMS vs Terra
- STARLIMS vs Valispace
- STARLIMS vs Wolfram Mathematica